Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey N Weitzel

Showing results (11-20 of 220) with videos related to

Pageof 22
Sort By:
Journal of Geriatric Oncology|January 26, 2020
Genetic cancer predisposition syndromes among older adultsYanin Chavarri-Guerra, Thomas P Slavin, Ossian Longoria-Lozano, et al.
Annals of Surgical Oncology|October 7, 2008
Contralateral risk-reducing mastectomy in young breast cancer patients with and without genetic cancer risk assessmentPhuong L Mai, Veronica I Lagos, Melanie R Palomares, et al.
Molecular Diagnosis & Therapy|January 29, 2013
Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directionsApril D Sorrell, Carin R Espenschied, Julie O Culver, et al.
Human Mutation|May 15, 2002
Restriction endonuclease fingerprinting enhanced conformation sensitive gel electrophoresis (REF-CSGE) in the analysis of BRCA1 exon 11 mutations in a high-risk breast cancer cohortJosef S Herzog, Erik M Jancis, Shidong Liao, et al.
Oncology Nursing Forum|March 7, 2006
Cancer screening and risk-reducing behaviors of women seeking genetic cancer risk assessment for breast and ovarian cancersDeborah J MacDonald, Linda Sarna, Gwen C Uman, et al.
Cancer Nursing|September 30, 2005
Health beliefs of women with and without breast cancer seeking genetic cancer risk assessmentDeborah J MacDonald, Linda Sarna, Gwen C Uman, et al.
Oncotarget|February 8, 2019
The effects of genomic germline variant reclassification on clinical cancer careThomas P Slavin, Sophia Manjarrez, Colin C Pritchard, et al.
CA: a Cancer Journal for Clinicians|August 23, 2011
Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized MedicineJeffrey N Weitzel, Kathleen R Blazer, Deborah J MacDonald, et al.
Plos One|October 8, 2011
RAD51C germline mutations in breast and ovarian cancer cases from high-risk familiesJessica Clague, Greg Wilhoite, Aaron Adamson, et al.
Familial Cancer|December 13, 2005
Linkage of a pedigree drawing program and database to a program for determining BRCA mutation carrier probabilitySharon R Sand, David S DeRam, Deborah J MacDonald, et al.
Pageof 22

Showing results (11-20 of 220) with videos related to

Sort By:
Pageof 22
Journal of Geriatric Oncology|January 26, 2020
Genetic cancer predisposition syndromes among older adultsYanin Chavarri-Guerra, Thomas P Slavin, Ossian Longoria-Lozano, et al.
Annals of Surgical Oncology|October 7, 2008
Contralateral risk-reducing mastectomy in young breast cancer patients with and without genetic cancer risk assessmentPhuong L Mai, Veronica I Lagos, Melanie R Palomares, et al.
Molecular Diagnosis & Therapy|January 29, 2013
Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directionsApril D Sorrell, Carin R Espenschied, Julie O Culver, et al.
Human Mutation|May 15, 2002
Restriction endonuclease fingerprinting enhanced conformation sensitive gel electrophoresis (REF-CSGE) in the analysis of BRCA1 exon 11 mutations in a high-risk breast cancer cohortJosef S Herzog, Erik M Jancis, Shidong Liao, et al.
Oncology Nursing Forum|March 7, 2006
Cancer screening and risk-reducing behaviors of women seeking genetic cancer risk assessment for breast and ovarian cancersDeborah J MacDonald, Linda Sarna, Gwen C Uman, et al.
Cancer Nursing|September 30, 2005
Health beliefs of women with and without breast cancer seeking genetic cancer risk assessmentDeborah J MacDonald, Linda Sarna, Gwen C Uman, et al.
Oncotarget|February 8, 2019
The effects of genomic germline variant reclassification on clinical cancer careThomas P Slavin, Sophia Manjarrez, Colin C Pritchard, et al.
CA: a Cancer Journal for Clinicians|August 23, 2011
Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized MedicineJeffrey N Weitzel, Kathleen R Blazer, Deborah J MacDonald, et al.
Plos One|October 8, 2011
RAD51C germline mutations in breast and ovarian cancer cases from high-risk familiesJessica Clague, Greg Wilhoite, Aaron Adamson, et al.
Familial Cancer|December 13, 2005
Linkage of a pedigree drawing program and database to a program for determining BRCA mutation carrier probabilitySharon R Sand, David S DeRam, Deborah J MacDonald, et al.
Pageof 22